BSBegoña Sánchez-López

Begoña Sánchez-López

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Begoña Sánchez-López has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Elisa Cabiscol

    Department de Ciències Mèdiques Bàsiques, IRBLleida, Universitat de Lleida, Catalonia, Spain

    2 shared publications
  • Fabien Delaspre

    Dept. Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida, Av. Alcalde Rovira Roure 80, Lleida, 25198, Spain; Institut de Recerca Biomèdica de Lleida - Fundació Dr. Pifarré, IRBLleida (ROR: 03mfyme49), Av. Alcalde Rovira Roure 80, Lleida, 25198, Spain

    2 shared publications
  • Laia Castells-Roca

    Dept. Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida, Av Rovira Roure 80, Lleida 25198, Spain; Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré (IRBLleida), Av. Alcalde Rovira Roure 80, Lleida 25198, Spain

    2 shared publications
  • Luiza Oliveira-Jorge

    Dept. Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida, Av Rovira Roure 80, Lleida 25198, Spain; Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré (IRBLleida), Av. Alcalde Rovira Roure 80, Lleida 25198, Spain

    2 shared publications
  • Maria Pazos-Gil

    Dept. Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida, Av. Alcalde Rovira Roure 80, Lleida, 25198, Spain; Institut de Recerca Biomèdica de Lleida - Fundació Dr. Pifarré, IRBLleida (ROR: 03mfyme49), Av. Alcalde Rovira Roure 80, Lleida, 25198, Spain

    2 shared publications
  • Marta Portillo-Carrasquer

    Dept. Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida, Av Rovira Roure 80, Lleida 25198, Spain; Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré (IRBLleida), Av. Alcalde Rovira Roure 80, Lleida 25198, Spain

    2 shared publications

Latest Publications

  • Open Access

    A CONSERVED AMINO ACID CLUSTER ENHANCES THERMAL STABILITY OF THE ANTIOXIDANT PROTEIN FRATAXIN

    by Luiza Oliveira-Jorge, Laia Castells-Roca, Maria Pazos-Gil, Marta Portillo-Carrasquer, Begoña Sánchez-López, Fabien Delaspre, Elisa Cabiscol, Joaquim Ros, Jordi Tamarit

    Friedreich ataxia is a rare cardio-neurodegenerative disease caused by reduced frataxin expression, resulting in iron-sulfur deficiency, oxidative stress sensitivity and decreased mitochondrial function. Sequence and structural analyses identified four residues—two serines, a tyrosine, and a glutamate—conserved across eukaryotic frataxins and Rickettsia CyaY proteins. Baker–Hubbard algorithm predicted that these residues form a hydrogen-bond network linking frataxin's α2 helix and β-sheet. To investigate the role of these residues, we engineered Saccharomyces cerevisae for expressing variant forms of yeast frataxin (Yfh1) at physiological levels. Mutating serines or glutamate caused partial protein loss. Oxygen consumption rate, specific aconitase activity and H2O2 sensitivity of these strains strongly correlated with remaining Yfh1 levels, suggesting that the investigated residues are required for frataxin stability but not for these functions. However, they showed high cupper sensitivity, indicating that these residues contribute to cuproptosis resistance. Furthermore, we purified wild-type human frataxin and variants E189A, S158A, S161A, Y143I, and Y143I/E189A. Thermal denaturation assays revealed that the variants decreased frataxin melting temperature (Tm), with the E189A variant exhibiting the most marked effect. This observation is consistent with the Baker–Hubbard prediction, as E189 is the only residue within the alfa-helix and is therefore essential for the H-bond network. Finally, we assessed the protective capacity of frataxin against metal-catalysed oxidation, confirming that frataxin presents antioxidant and iron-binding properties. We can conclude that frataxin presents metal-binding an antioxidant capacity and that the conserved residues investigated increase frataxin thermal stability and resistance to cuproptosis.

  • Open Access

    Targeting frataxin deficiency in DRG neurons and fibroblasts: omaveloxolone restores metabolic and iron balance to reduce ferroptosis

    by Marta Portillo-Carrasquer, Arabela Sanz-Alcázar, Begoña Sánchez-López, Fabien Delaspre, Maria Pazos-Gil, Luiza Oliveira-Jorge, Laia Castells-Roca, Jordi Tamarit, Joaquim Ros, Elisa Cabiscol